Similar articles

• Prevention of fetal growth retardation with low-dose aspirin: findings of the EPREDA trial.

  Uzan S, Beaufils M, Breart G, Bazin B, Capitant C, Paris J. Uzan S, et al. Lancet. 1991 Jun 15;337(8755):1427-31. doi: 10.1016/0140-6736(91)93124-r. Lancet. 1991. PMID: 1675315 Clinical Trial.
• Low dose aspirin for preventing fetal growth restriction: a randomised trial.

  Stanescu AD, Banica R, Sima RM, Ples L. Stanescu AD, et al. J Perinat Med. 2018 Sep 25;46(7):776-779. doi: 10.1515/jpm-2017-0184. J Perinat Med. 2018. PMID: 29381473 Clinical Trial. No abstract available.
• Low-dose aspirin and nulliparae.

  Davies NJ, Farquharson RG, Walkinshaw Sa. Davies NJ, et al. Lancet. 1991 Aug 3;338(8762):324. doi: 10.1016/0140-6736(91)90471-z. Lancet. 1991. PMID: 1677150 Clinical Trial. No abstract available.
• An aspirin a day to prevent prematurity.

  Sibai BM. Sibai BM. Clin Perinatol. 1992 Jun;19(2):305-17. Clin Perinatol. 1992. PMID: 1617877 Review.
• Platelet anti-aggregatory therapy in pregnancy: another role for low dose aspirin?

  Seneviratne HR, Weerasinghe WM. Seneviratne HR, et al. Ceylon Med J. 1990 Mar;35(1):5-9. Ceylon Med J. 1990. PMID: 2193716 Review. No abstract available.